ECHOLANDS WINERY WINS HIGHEST WASHINGTON TROPHY AT THE 2025 DECANTER MAGAZINE WORLD WINE AWARDS!
The 97-point score was bestowed by an august group of judges, comprising mostly Master Sommeliers and Masters of Wine. "Winning a Gold or Platinum award at DWWA can literally change a producer's life," said DWWA judge and Master of Wine Tim Marson. The judges noted that Echolands' Blue Mountain Vineyard Cabernet Franc has, "an unrivalled purity of fruit: black cherry, berry and plum with a distinctive earthy, herbaceous tone. Mouth-filling and appetising with lustrous tannins and a beam of juicy acidity which undulates towards the long, smoky finish."
Celebrating its 22nd edition, the Decanter World Wine Awards remain the world's largest and most influential wine competition. This year, wines from 57 countries were evaluated by 248 top international experts, including 22 Master Sommeliers and 72 Masters of Wine – the most in the competition's history.
Though Frost and the Echolands team rely primarily upon their own vines for their fruit, there are special places in Walla Walla Valley that offer distinct expressions with certain grapes. "Blue Mountain Vineyard is a beautiful vineyard that is nestled in the foothills of the Blue Mountains and that is cooler than vineyards on the valley floor," Frost says. "That alone accounts for the lovely tension that we taste in the Cabernet Franc we buy from them. But it's an impeccably managed vineyard as well."
Echolands buys a select amount of fruit from a few neighboring vineyards, like the esteemed Blue Mountain Vineyard. "The Cabernet Franc that we pick at Blue Mountain Vineyard is really special," says winemaker Brian Rudin. "It's a complex and more aromatic version of the grape than you get from other, particularly warmer, sites," he says.
Walla Walla's famous Seven Hills Vineyard was the source for Echolands' Silver Medal-winning Seven Hills Vineyard Red 2020. Echolands' own Taggart Vineyard provided the Sauvignon Blanc and Semillon grapes for their Silver Medal-winning Albus Taggart Vineyard 2023.
Echolands Winery was founded in 2018 by renowned Master Sommelier and Master of Wine Doug Frost, in partnership with investor and conservationist Brad Bergman. Winemaker Brian Rudin manages the winery's 24-acre Taggart Vineyard on the Oregon side of the Walla Walla Valley, as well as the Echolands Estate Vineyard's 28 acres of vines on the Washington side of the valley. This is the first proprietary winery project for wine consultant and writer Doug Frost, one of only four people in the world to hold both the Master of Wine and Master Sommelier titles.
"We chose the name Echolands to reflect our fundamental reliance on the landscape, the vines and the very special sites where our wines are grown," says Doug Frost, CEO and Owner of Echolands Winery. "In truth, all wine is an echo of the landscape, of the vines planted there and the sound that they make in the form of their fruits. Winemaking cannot create qualities that are not there in the grapes. Like the creature of mythology known as Echo, we can only express what is given to us."
View original content to download multimedia:https://www.prnewswire.com/news-releases/echolands-winery-wins-highest-washington-trophy-at-the-2025-decanter-magazine-world-wine-awards-302488757.html
SOURCE Echolands Winery
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Business Wire
an hour ago
- Business Wire
Frost & Sullivan Recognizes Novotech as 2025 Global Biotech CRO Company of the Year
SYDNEY--(BUSINESS WIRE)--In recognition of its innovation, client-focused delivery, and global impact, Novotech has been awarded the 2025 Global Biotechnology Contract Research Organization (CRO) Company of the Year by Frost & Sullivan. In recognition of its innovation, client-focused delivery, and global impact, Novotech has been awarded the 2025 Global Biotechnology Contract Research Organization (CRO) Company of the Year by Frost & Sullivan. Share Novotech is a globally recognized full-service clinical CRO and scientific advisory firm, trusted by biotech and small- to mid-sized pharmaceutical companies to advance their drug development programs at every phase. With a global footprint spanning Asia-Pacific, North America, and Europe, Novotech supports over 5,000 clinical trial sites and a distributed team of experts delivering seamless, end-to-end solutions across geographies. 'Novotech is redefining biotech-focused clinical research through AI-driven innovation, global expansion, and a client-embedded partnership model. With a clear vision to be the CRO of choice for small to mid-size biotech, Novotech leverages deep therapeutic expertise and regional agility to deliver speed, flexibility, and transformative impact in clinical trials.' — Unmesh Lal, Vice President – Healthcare & Life Sciences, Frost & Sullivan According to Frost & Sullivan, Novotech's client-first approach, coupled with its scale and scientific capabilities, continues to set it apart in the biotech CRO space. The firm's deep therapeutic expertise in oncology, rare diseases, infectious diseases, and advanced modalities—such as gene therapies and RNA-based treatments—was cited as a key differentiator. The award also acknowledged Novotech's ability to maintain trial continuity and delivery excellence amid geopolitical, operational, and economic volatility. Strategic use of AI-enabled tools, predictive analytics, and real-time data platforms further enables Novotech to accelerate timelines and improve decision-making for biotech sponsors. 'We're honored by Frost & Sullivan's recognition, which highlights Novotech's strategic focus on delivering regional expertise through a global model to support biotech and mid-size pharma sponsors. It also reflects the strength of our teams in driving operational, scientific, and client delivery excellence worldwide.' — Dr. John Moller, CEO, Novotech Unmesh Lal added: 'Frost & Sullivan believes Novotech's road ahead is about growing without losing its soul: scaling globally while staying deeply connected to biotech clients, preserving its cultural DNA, and delivering the high-touch, high-value service that has become its hallmark.' The award was accepted on behalf of Novotech by Scott Schliebner, Vice President of Drug Development Consulting, during the Frost & Sullivan Excellence in Best Practices Awards Gala held in Los Angeles, California, on June 26. About Novotech Novotech is a globally recognized full-service clinical research organization (CRO) and scientific advisory company trusted by biotech and small- to mid-sized pharmaceutical companies to guide drug development at every phase. With a global footprint that includes 30+ offices across the Asia-Pacific region, North America, and Europe and partnerships with 5,000+ trial sites, Novotech provides clients an accelerated path to bring life-changing therapies to market by providing access to key clinical trial destinations and diverse patient populations. Through its client-centric service model, Novotech seamlessly integrates people, processes, and technologies to deliver customized solutions that accelerate the path to market for life-changing therapies. By adopting a true partnership approach, Novotech shares a steadfast commitment to client success, empowering innovation, and advancing healthcare worldwide. Recipient of numerous industry accolades, including the Frost & Sullivan CRO Company of the Year award for 19 consecutive years, Novotech is recognized for its excellence in clinical trial execution and innovation. Its deep therapeutic and regulatory expertise, combined with local market insights, ensures streamlined clinical trials, optimized data analytics, and accelerated patient recruitment strategies. Together with clients, Novotech transforms scientific advancements into therapies that improve global health outcomes, embodying a mission of driving innovation and delivering impactful results. For more information or to speak to an expert team member visit


Eater
17 hours ago
- Eater
What to Eat at D.C.'s Top Tennis Tournament
A record count of Michelin-starred restaurants — seven in all – will serve at the Mubadala Citi DC Open. The week-long event at Rock Creek Tennis Center (Saturday, July 19-Sunday, July 27) — the only combined men's and women's 500-level tennis tournament in the world — draws more than 70,000 fans each year to the William H.G. FitzGerald Tennis Center (5220 16th Street NW). After debuting at the then-named Citi Open in 2023, three-Michelin-starred Inn at Little Washington returns with truffle popcorn from chef and proprietor Patrick O'Connell (still only available in the Citi Lounge and suites only, however). Nick Stefanelli of NoMa's Masseria plates Italian cuisine, and chefs Miguel Guerra and Tatiana Mora of newly starred Mita will serve polished vegetable dishes. Others offering off-court delights include Albi's James Beard Award-winning chef Michael Rafidi, Spanish celebrity chef José Andrés's cooling gazpacho for the hot tennis nights, and chef Jeremiah Langhorne of The Dabney, who plans to prep his mid-Atlantic catfish sandwiches on sweet potato rolls. Debuting this year is Ben's Chili Bowl, U Street's decades-old institution serving its iconic half-smokes. And Cava, the now-national chain born in the DMV, also brings its Mediterranean bowls to the tournament for the first time. Held every year since 1969, the pro tournament kicked off a partnership with Abu Dhabi-based Mubadala Investments in 2023 to create the newly named Mubadala Citi DC Open. This June, D.C. officials announced big plans to assume control of Rock Creek Tennis Center and modernize the area and facility, which is currently owned by the federal government. The city says it wants to work in partnership with the tournament's owner Mark Ein, who has goals of his own to continue to upgrade the annual event. This year's competitive roster features seven top-10 players across the ATP and WTA Tours, and five Grand Slam champions, including D.C.-area native and World No. 12-ranked Frances Tiafoe. Tickets, starting in the $30s, are still available. Green turf-lined Market Square remains where the majority of the food action takes place. Returning favorites around the DMV includes King Street Oyster Bar (lobster rolls), Roaming Rooster (hot Nashville fried chicken sandwiches), and Duke's Grocery (Proper Burger). There's also sweets from Dolcezza and Clayboy's Shaved Ice; and Ladurée will offer its macarons at a special stand outside the main stadium. Design Cuisine returns again as the tournament's concessionaire. The tourney isn't complete without its range of drinks, alcoholic and N/A. Over at the Tequila Lounge, sponsor Mi Campo Tequila teams up with D.C.-born Taco Bamba. Chef and owner Victor Albisu is a longstanding tennis fan, spotted in the stadium for several years. The rock-and-roll Mexican spot – there since 2022 – will offer a range of tacos, grilled guacamole, loaded nachos, and two types of churros. 'We're a big tennis family, and this is one of my favorite events,' says Albisu. Several returning places for tippling include: wine-centric Kim Crawford Summer Club, Aviation Gin Bar, Ketel One Terrace, and Heineken Beer Garden – all with dedicated drinks and some limited food options.


The Hill
a day ago
- The Hill
Maxwell Frost: 20 House Republicans a ‘no' on ‘big, beautiful bill'
House Democrats are trying to delay passage of President Trump's mammoth tax and spending measure because 'about 20 Republicans' currently oppose the bill and more may join them as pressure mounts, Rep. Maxwell Frost (D-Fla.) said Tuesday evening. 'They can only lose three or four [votes], and it's done,' Frost told MSNBC's Jen Psaki in an interview after the Senate narrowly passed the 'One Big Beautiful Bill Act' following a marathon debate and efforts to tamp down pushback from moderate Republicans in the GOP-controlled upper chamber. Frost said discussions are ongoing with moderates and ultra conservative House Republicans who have spoken out about various provisions of the bill, which would extend the tax cuts from Trump's first term while cutting funding for social safety net programs like Medicaid and food stamps, but he argued GOP members on both fronts seem to 'always fold.' 'They put up a little fight, so that way they have some footage that they can put behind their ads during election time, and then they fold right away,' Frost said. 'Sometimes they stick to it, so we'll see.' 'But the most important conversations — the most impactful ones — are actually [with] constituents and the people reaching out, and that's why the big strategy right now is delay,' he added. The House returned to the Capitol on Wednesday to hash out disagreements over the Senate version of the bill, as House Speaker Mike Johnson (R-La.), Trump and Republican allies push for its passage by their self-imposed deadline Friday. The House narrowly passed its own version of the bill in May after Trump, Vice President Vance and Republican leaders pressured skeptical members to send the bill to the Senate so debate could continue while racing toward the president's Independence Day deadline. Frost told Psaki on Tuesday that it's imperative for Democrats, aided by public pressure, to kill the 'horrible bill' and he views time as their biggest advantage. 'Every minute we keep this bill from passing, it becomes even more unpopular, and every minute we keep it from passing, that means there's more people going to the district offices, calling the offices in D.C., sending letters, protesting, reaching on social media,' Frost said. 'When that compiles, we get to the point where hopefully many of these members will stick to it and vote 'no,' and that's our goal,' he continued.